CHESTGuidelines & Topic CollectionsA Review of ACR/CHEST Clinical Practice Guidelines on Treatment of ILD With Systemic Autoimmune Rheumatic Diseases

A Review of ACR/CHEST Clinical Practice Guidelines on Treatment of ILD With Systemic Autoimmune Rheumatic Diseases

Recorded: May 1, 2024

The American College of Rheumatology (ACR) and American College of Chest Physicians (CHEST) recently released clinical practice guidelines for the screening, monitoring, and treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases, including systemic sclerosis, rheumatoid arthritis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren’s disease. These guidelines—the first of their kind—aimed to promote screening in high-risk patients that could lead to early interventions to prevent or slow progression of this highly morbid and lethal pulmonary disease. This webinar features a multidisciplinary panel discussion of pulmonologists and rheumatologists who will critically review these guidelines and provide commentary on the clinical implications of their implementation.

This webinar was developed by CHEST’s Diffuse Lung Disease and Lung Transplant Network.



Host

Anthony J. Esposito, MD

Host

Tejaswini Kulkarni, MD, MBBS, FCCP

Chair, Interstitial Lung Disease Section

Panelist

Elana Bernstein, MD, MSc

Panelist

Sonye K. Danoff, MD, PhD, FCCP

Panelist

Kristin B. Highland, MD